Metastatic Basal cell carcinoma

Also known as: Metastatic basal cell carcinoma (BCC) / Metastatic basal cell carcinoma (morphologic abnormality) / Basal cell carcinoma metastatic / Metastatic basal cell carcinoma (disorder)

DrugDrug NameDrug Description
DB14707CemiplimabA programmed death receptor-1 blocking antibody used to treat cutaneous squamous cell carcinoma, basal cell carcinoma, and non-small cell lung cancer.
DB08828VismodegibA hedgehog pathway inhibitor used to treat patients with locally advanced or metastatic basal cell carcinoma.
DrugDrug NamePhaseStatusCount
DB14681Cortisone1Active Not Recruiting1
DB06186Ipilimumab1Active Not Recruiting1
DB00959Methylprednisolone1Active Not Recruiting1
DB09035Nivolumab1Active Not Recruiting1
DB00635Prednisone1Active Not Recruiting1
DB00864Tacrolimus1Active Not Recruiting1
DB14681Cortisone1 / 2Recruiting1
DB06186Ipilimumab1 / 2Recruiting1
DB00959Methylprednisolone1 / 2Recruiting1
DB09035Nivolumab1 / 2Recruiting1
DB00635Prednisone1 / 2Recruiting1
DB00877Sirolimus1 / 2Recruiting1
DB08828Vismodegib4Completed1
DB09143SonidegibNot AvailableRecruiting1
DB08828VismodegibNot AvailableRecruiting1